$TEM SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Other Events On October 23, 2026, Tempus AI, Inc. (“Tempus”) announced that it had entered into a series of agreements with Bristol-Myers Squibb Company (“BMS”) and Pathos AI, Inc. (“Pathos”) to expand the use of Tempus’s de-identified multimodal rea...
21 Oct 2026	EFFECT
21 Oct 2026	424B3
20 Oct 2026	S-4/A
02 Oct 2026	S-4/A
29 Sep 2026	Form 4: Schoenherr Thomas Edward, CEO, Diagnostics Sold 10,281 shares ($874K)
25 Sep 2026	144
24 Sep 2026	Form 4: Lefkofsky Eric P, Director Sold 250,000 shares ($19.4M)
22 Sep 2026	144
18 Sep 2026	Form 4: Fukushima Ryan, CEO, Data Sold 700 shares ($49K)
18 Sep 2026	Form 4: Polovin Andrew, EVP, Chief Legal Officer Sold 2,951 shares ($221K)
18 Sep 2026	Form 4: Bartolucci Ryan M, Chief Accounting Officer Sold 7,062 shares ($530K)
18 Sep 2026	Form 4: Lefkofsky Eric P, Director Sold 200,000 shares ($16.1M)
17 Sep 2026	144
17 Sep 2026	144
17 Sep 2026	144
16 Sep 2026	144
15 Sep 2026	425
03 Sep 2026	Form 4: Fukushima Ryan, CEO, Data Sold 30,846 shares ($1.93M)
03 Sep 2026	Form 4: Doudna Jennifer A, Director Sold 676 shares ($44.3K)

Comments